Medis Technologies Ltd: Medis Technologies Completes Underwriters Laboratories Certification for 24/7 Power Pack — Receives UL Listing and Use of Mark
Medis Technologies Completes Underwriters Laboratories Certification for 24/7 Power Pack — Receives UL Listing and Use of Mark
NEW YORK, NY —
(MARKET WIRE) — December 26, 2006 — Medis Technologies Ltd. (NASDAQ: MDTL)announced today that its 24/7 Power Pack has completed UnderwritersLaboratories (UL) certification and is listed under UL number IRGU.MH45617.Medis’ wholly owned subsidiary More Energy Ltd. has been advised by UL thatit has satisfied the final step for UL certification — the InitialProduction Inspection (IPI) for its production line in Israel and has theright to apply the UL mark on the Power Packs produced on that line, whichit is now doing.
“The completion of UL certification of the 24/7 Power Pack is a remarkableachievement,” said Robert K. Lifton, Chairman and CEO of Medis TechnologiesLtd. “Congratulations to the More Energy team led by our Chief TechnologyOfficer, Gennadi Finkelshtain for inventing an entirely novel approach tofuel cell technology, developing the 24/7 Power Pack using unique solutionsand producing the Power Pack product that meets these high UL standards.This marks the completion of the Power Pack development phase, and we turnour full focus to product sales and high volume manufacturing.”
Medis Technologies’ primary focus is on direct liquid fuel cell technology.Its business strategy is to sell its products to end users through retailoutlets, service providers and to the military and other markets. Medis hasalso developed the CellScan with many potential applications relating todisease diagnostics and chemo sensitivity. Additionally, Medis’ productpipeline includes other technologies, in varying stages of development.
This press release may contain forward-looking statements, which are madepursuant to the safe harbor provisions of the Private Securities LitigationReform Act of 1995. In some cases you can identify those so-called”forward-looking statements” by words such as “may,” “will,” “should,”"expects,” “plans,” “targets,” “believes,” “anticipates,” “estimates,”"predicts,” “potential,” or “continue” or the negative of those words andother comparable words. These forward-looking statements are subject torisks and uncertainties, product tests, commercialization risks,availability of financing and results of financing efforts that could causeactual results to differ materially from historical results or thoseanticipated. Further information regarding these and other risks isdescribed from time to time in the Company’s filings with the SEC. Weassume no obligation to update or alter our forward-looking statements madein this release or in any periodic report filed by us under the SecuritiesExchange Act of 1934 or any other document, whether as a result of newinformation, future events or otherwise, except as otherwise required byapplicable federal securities laws.
This press release is available on Medis’ web site atwww.medistechnologies.com.
Popularity: 1% [?]
